Related references
Note: Only part of the references are listed.Involvement of matrix metalloproteinases (MMPs) and inflammasome pathway in molecular mechanisms of fibrosis
Sacha Robert et al.
BIOSCIENCE REPORTS (2016)
P2Y12 Receptor Antagonists: Which One to Choose? A Systematic Review and Meta-Analysis
Alexandros Briasoulis et al.
CURRENT PHARMACEUTICAL DESIGN (2016)
Purinergic signaling in retinal degeneration and regeneration
Andreas Reichenbach et al.
NEUROPHARMACOLOGY (2016)
The NLRP3 inflammasome: Physiopathology and therapeutic application
Thomas Gicquel et al.
PRESSE MEDICALE (2016)
Pirfenidone, nintedanib and N-acetylcysteine for the treatment of idiopathic pulmonary fibrosis: A systematic review and meta-analysis
Paola Rogliani et al.
PULMONARY PHARMACOLOGY & THERAPEUTICS (2016)
P2X ion channel receptors and inflammation
Geoffrey Burnstock
PURINERGIC SIGNALLING (2016)
Promising Therapeutic Potential of P2X7 Modulators
Ahmed F. Abdel-Magid
ACS MEDICINAL CHEMISTRY LETTERS (2016)
Real World Experiences: Pirfenidone and Nintedanib are Effective and Well Tolerated Treatments for Idiopathic Pulmonary Fibrosis
Gareth Hughes et al.
JOURNAL OF CLINICAL MEDICINE (2016)
Pirfenidone and nintedanib modulate properties of fibroblasts and myofibroblasts in idiopathic pulmonary fibrosis
Siri T. Lehtonen et al.
RESPIRATORY RESEARCH (2016)
Understanding the roles of the P2X7 receptor in solid tumour progression and therapeutic perspectives
Sebastien Roger et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2015)
Genetic and Pharmacological Inactivation of the Purinergic P2RX7 Receptor Dampens Inflammation but Increases Tumor Incidence in a Mouse Model of Colitis-Associated Cancer
Paul Hofman et al.
CANCER RESEARCH (2015)
P2X Receptors and Inflammation
Francesco Virgilio
CURRENT MEDICINAL CHEMISTRY (2015)
Involvement of the P2X7 Purinergic Receptor in Inflammation: An Update of Antagonists Series Since 2009 and their Promising Therapeutic Potential
Davy Baudelet et al.
CURRENT MEDICINAL CHEMISTRY (2015)
IL-1β production is dependent on the activation of purinergic receptors and NLRP3 pathway in human macrophages
Thomas Gicquel et al.
FASEB JOURNAL (2015)
P2X7 Receptor as a Key Player in Oxidative Stress-Driven Cell Fate in Nonalcoholic Steatohepatitis
Saurabh Chatterjee et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2015)
The NLRP3 inflammasome is activated by nanoparticles through ATP, ADP and adenosine
L. Baron et al.
CELL DEATH & DISEASE (2015)
P2RX7 Purinoceptor: A Therapeutic Target for Ameliorating the Symptoms of Duchenne Muscular Dystrophy
Anthony Sinadinos et al.
PLOS MEDICINE (2015)
Pharmacological treatment of idiopathic pulmonary fibrosis - preclinical and clinical studies of pirfenidone, nintedanib, and N-acetylcysteine
Marjukka Myllarniemi et al.
EUROPEAN CLINICAL RESPIRATORY JOURNAL (2015)
Cellular Mechanisms of Tissue Fibrosis. 6. Purinergic signaling and response in fibroblasts and tissue fibrosis
David Lu et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2014)
Purinergic receptor P2X(7): A novel target for anti-inflammatory therapy
Nisha Mehta et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2014)
Involvement of purinergic receptors and NOD-like receptor-family protein 3-inflammasome pathway in the adenosine triphosphate-induced cytokine release from macrophages
Thomas Gicquel et al.
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (2014)
Role of Pannexin-1 hemichannels and purinergic receptors in the pathogenesis of human diseases
Stephani Velasquez et al.
FRONTIERS IN PHYSIOLOGY (2014)
Anti-fibrotic effects of nintedanib in lung fibroblasts derived from patients with idiopathic pulmonary fibrosis
Katrin E. Hostettler et al.
RESPIRATORY RESEARCH (2014)
Effect of the Purinergic Inhibitor Oxidized ATP in a Model of Islet Allograft Rejection
Andrea Vergani et al.
DIABETES (2013)
P2X7R: A potential key regulator of acute gouty arthritis
Jin-Hui Tao et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2013)
Heteromeric assembly of P2X subunits
Anika Saul et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2013)
Immunity, inflammation and cancer: a leading role for adenosine
Luca Antonioli et al.
NATURE REVIEWS CANCER (2013)
Clinical evaluation of the efficacy of the P2X7 purinergic receptor antagonist AZD9056 on the signs and symptoms of rheumatoid arthritis in patients with active disease despite treatment with methotrexate or sulphasalazine
Edward C. Keystone et al.
ANNALS OF THE RHEUMATIC DISEASES (2012)
The His155Tyr (489C>T) single nucleotide polymorphism of P2RX7 gene confers an enhanced function of P2X7 receptor in immune cells from patients with rheumatoid arthritis
Liliana Portales-Cervantes et al.
CELLULAR IMMUNOLOGY (2012)
P2X7 receptor-NADPH oxidase axis mediates protein radical formation and Kupffer cell activation in carbon tetrachloride-mediated steatohepatitis in obese mice
Saurabh Chatterjee et al.
FREE RADICAL BIOLOGY AND MEDICINE (2012)
Inflammasomes in liver diseases
Gyongyi Szabo et al.
JOURNAL OF HEPATOLOGY (2012)
P2Y6 Receptor Signaling Pathway Mediates Inflammatory Responses Induced by Monosodium Urate Crystals
Hideya Uratsuji et al.
JOURNAL OF IMMUNOLOGY (2012)
Purinergic Signaling in Healthy and Diseased Skin
Geoffrey Burnstock et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2012)
Efficacy and Safety of CE-224,535, an Antagonist of P2X7 Receptor, in Treatment of Patients with Rheumatoid Arthritis Inadequately Controlled by Methotrexate
Thomas C. Stock et al.
JOURNAL OF RHEUMATOLOGY (2012)
Adenosine Triphosphate Induced P2Y2 Receptor Activation Induces Proinflammatory Cytokine Release in Uroepithelial Cells
Robert Kruse et al.
JOURNAL OF UROLOGY (2012)
Inflammasomes: current understanding and open questions
Franz Bauernfeind et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2011)
A potential therapeutic role for P2X7 receptor (P2X7R) antagonists in the treatment of inflammatory diseases
Nishkantha Arulkumaran et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2011)
Transcriptional control mechanisms associated with the nucleotide receptor P2X7, a critical regulator of immunologic, osteogenic, and neurologic functions
Lisa Y. Lenertz et al.
IMMUNOLOGIC RESEARCH (2011)
Cutting Edge: Reactive Oxygen Species Inhibitors Block Priming, but Not Activation, of the NLRP3 Inflammasome
Franz Bauernfeind et al.
JOURNAL OF IMMUNOLOGY (2011)
Immune cell regulation by autocrine purinergic signalling
Wolfgang G. Junger
NATURE REVIEWS IMMUNOLOGY (2011)
Amplification loop of the inflammatory process is induced by P2X7R activation in intestinal epithelial cells in response to neutrophil transepithelial migration
Annabelle Cesaro et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2010)
Extracellular ATP Is a Danger Signal Activating P2X7 Receptor in Lung Inflammation and Fibrosis
Nicolas Riteau et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2010)
Lack of the purinergic receptor P2X7 results in resistance to contact hypersensitivity
Felix C. Weber et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2010)
Ivermectin-dependent release of IL-1beta in response to ATP by peritoneal macrophages from P2X7-KO mice
Michele Seil et al.
PURINERGIC SIGNALLING (2010)
The NLRP3 Inflammasome: A Sensor for Metabolic Danger?
Kate Schroder et al.
SCIENCE (2010)
Uric Acid Is a Danger Signal Activating NALP3 Inflammasome in Lung Injury Inflammation and Fibrosis
Pamela Gasse et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2009)
Signaling at Purinergic P2X Receptors
Annmarie Surprenant et al.
ANNUAL REVIEW OF PHYSIOLOGY (2009)
The antihyperalgesic activity of a selective P2X7 receptor antagonist, A-839977, is lost in IL-1αβ knockout mice
Prisca Honore et al.
BEHAVIOURAL BRAIN RESEARCH (2009)
Purinergic receptors in airway epithelia
Eduardo R. Lazarowski et al.
CURRENT OPINION IN PHARMACOLOGY (2009)
A Functional P2X7 Splice Variant with an Alternative Transmembrane Domain 1 Escapes Gene Inactivation in P2X7 Knock-out Mice
Annette Nicke et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Nucleotides released by apoptotic cells act as a find-me signal to promote phagocytic clearance
Michael R. Elliott et al.
NATURE (2009)
ATP-gated P2X cation-channels
Michael F. Jarvis et al.
NEUROPHARMACOLOGY (2009)
Block of purinergic P2X7 receptor is neuroprotective in an animal model of Alzheimer's disease
Jae K. Ryu et al.
NEUROREPORT (2008)
Evidence for functional P2X4/P2X7 heteromeric receptors
Chang Guo et al.
MOLECULAR PHARMACOLOGY (2007)
Extracellular ATP triggers and maintains asthmatic airway inflammation by activating dendritic cells
Marco Idzko et al.
NATURE MEDICINE (2007)
Purine and pyrimidine receptors
G. Burnstock
CELLULAR AND MOLECULAR LIFE SCIENCES (2007)
Pannexin1 is part of the pore forming unit of the P2X7 receptor death complex
Silviu Locovei et al.
FEBS LETTERS (2007)
Adenosine 5′-triphosphate and adenosine as endogenous signaling molecules in immunity and inflammation
M. J. L. Bours et al.
PHARMACOLOGY & THERAPEUTICS (2006)
P2X receptors as cell-surface ATP sensors in health and disease
Baljit S. Khakh et al.
NATURE (2006)
Pharmacology of P2X channels
Joel R. Gever et al.
PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY (2006)
The P2X7 receptor:: A key player in IL-1 processing and release
Davide Ferrari et al.
JOURNAL OF IMMUNOLOGY (2006)
Cryopyrin activates the inflammasome in response to toxins and ATP
S Mariathasan et al.
NATURE (2006)
Gout-associated uric acid crystals activate the NALP3 inflammasome
F Martinon et al.
NATURE (2006)
COX-2, CB2 and P2X7-immunoreactivities are increased in activated microglial cells/macrophages of multiple sclerosis and amyotrophic lateral sclerosis spinal cord
Y Yiangou et al.
BMC NEUROLOGY (2006)
Overview of the P2 receptors
JM Boeynaems et al.
SEMINARS IN THROMBOSIS AND HEMOSTASIS (2005)
Alerting and tuning the immune response by extracellular nucleotides
A la Sala et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2003)
Liver fibrosis - from bench to bedside
SL Friedman
JOURNAL OF HEPATOLOGY (2003)
Differences in the fibrogenic response after transfer of active transforming growth factor-β1 gene to lungs of fibrosis-prone and fibrosis-resistant mouse strains
M Kolb et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2002)
Proteomic and functional evidence for a P2X7 receptor signalling complex
M Kim et al.
EMBO JOURNAL (2001)
Idiopathic pulmonary fibrosis: Prevailing and evolving hypotheses about its pathogenesis and implications for therapy
M Selman et al.
ANNALS OF INTERNAL MEDICINE (2001)
Unique functional properties of a sensory neuronal P2X ATP-gated channel from zebrafish
E Boué-Grabot et al.
JOURNAL OF NEUROCHEMISTRY (2000)
Share Paper
